Skip to main content

Advertisement

Table 2 Median overall survival (MOS)* for female breast cancer patients

From: Effects of payer status on breast cancer survival: a retrospective study

  Factor Level n MOS Lower Upper
Group factors All Patients   976178 14.75 14.69 14.84
Demographic Age (Years) 18-49 252080 >14.99 N/A N/A
50-64 354102 >14.99 14.94 N/A
65-74 192042 13.59 13.48 13.73
≥75 177954 7.14 7.1 7.18
Race White 851863 14.77 14.71 14.86
Black 98641 13.25 13.03 13.66
Others 25674 >14.95 N/A N/A
Education (%), did not graduate from high school ≥29 144440 13.5 13.35 13.74
20-28 202583 14.09 13.95 14.16
14-19 217587 14.49 14.37 14.64
<14 366118 14.92 14.9 N/A
Clinical characteristic Stage Stage I 468222 14.99 14.92 N/A
Stage II 361618 14.78 14.69 14.94
Stage III 101260 7.81 7.7 7.91
Stage IV 45078 1.7 1.67 1.73
Charlson Comorbidity 0 375270 10.33 10.16 N/A
1 41661 9.6 9.45 9.85
≥2 8322 5.58 5.4 5.81
Unknown 550925 14.71 14.67 14.8
Access to health care Payer Status Uninsured 24849 >14.89 14.06 N/A
Private 542805 15 N/A N/A
Medicaid 41718 13.08 12.84 13.85
Medicare 334182 10.13 10.08 10.18
Unknown 32624 14.56 14.31 N/A
Income ($1000) <30 117919 12.77 12.65 12.92
30-34 158762 13.92 13.79 14.05
35-45 256013 14.47 14.33 14.51
≥46 398086 14.92 14.9 N/A
Distance Travelled (Miles) <10 556476 14.58 14.47 14.66
10-24 234049 15 N/A N/A
25-49 88994 14.77 14.63 N/A
50-99 39053 >14.94 14.64 N/A
≥100 22349 14.99 N/A N/A
Cancer Program Community 110174 13.72 13.56 13.83
Comprehensive 563299 14.75 14.69 14.86
Academic Research 261484 >14.99 14.9 N/A
Others 41221 12.49 12.19 13.12
Diagnosing/Treating Facility Same 662498 14.61 14.5 14.67
Different 313680 14.91 14.86 N/A
Treatment Delay (Days) 0-5 296904 14.76 14.69 14.92
6-20 284321 14.86 14.77 N/A
21-30 155774 14.84 14.67 N/A
≥31 193455 14.45 14.24 14.7
  1. *All p-values <0.0001 by using Logrank Test. Median Overall Survival (MOS). N/A: not reached.